Cytokinetics Announces Data From Phase 1 Study of CK-4021586
Go back to Cytokinetics Announces Data From Phase 1 Study of CK-4021586| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 65.81 -1.78 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.59 | 52 Week High | $13.18 | |||
| Open | $67.02 | 52 Week Low | $6.00 | |||
| Day High | $67.39 | P/E | N/A | |||
| Day Low | $64.73 | EPS | $-1.24 | |||
| Volume | 2,050,948 | |||||
